BRIT J PSYCHIAT :精神病患者罹患躯体疾病时获得躯体疾病治疗药物处方量低

2012-12-14 BRIT J PSYCHIAT BRIT J PSYCHIAT

  英国和新西兰联合研究显示,医生倾向于给重性精神病患者开具远低于常规剂量的药物治疗躯体疾病,尤其是治疗心血管疾病的药物。论文发表于《英国精神病学杂志》[Br J Psychiatry 2012,201(6):435]。   研究者选取涉及心血管健康、糖尿病、肿瘤、关节炎、骨质疏松及人类免疫缺陷病毒(HIV)感染等12类药物处方的61项研究,共1931509例患者。

  英国和新西兰联合研究显示,医生倾向于给重性精神病患者开具远低于常规剂量的药物治疗躯体疾病,尤其是治疗心血管疾病的药物。论文发表于《英国精神病学杂志》[Br J Psychiatry 2012,201(6):435]。

  研究者选取涉及心血管健康、糖尿病、肿瘤、关节炎、骨质疏松及人类免疫缺陷病毒(HIV)感染等12类药物处方的61项研究,共1931509例患者。结果为,存在严重精神障碍者,获得适当处方的校正OR为0.74,尤其在获得血管紧张素转换酶抑制剂或血管紧张素Ⅱ受体阻滞剂(ACEI/ARB)、β受体阻滞剂及他汀类药物处方量方面低于预期;存在情感障碍者,此OR值为0.75;存在其他精神疾病史者,OR值为0.95,其获得ACEI/ARB处方量较低,但在接受高效抗病毒治疗方面与常规剂量并无差异。




Background
There is some concern that patients with mental illness may be in receipt of inferior medical care, including prescribed medication for medical conditions.
Aims
We aimed to quantify possible differences in the prescription of medication for medical conditions in those with v. without mental illness.
Method
Systematic review and random effects meta-analysis with a minimum of three independent studies to warrant pooling by drug class.
Results
We found 61 comparative analyses (from 23 publications) relating to the prescription of 12 classes of medication for cardiovascular health, diabetes, cancer, arthritis, osteoporosis and HIV in a total sample of 1 931 509 people. In those with severe mental illness the adjusted odds ratio (OR) for an equitable prescription was 0.74 (95% CI 0.63–0.86), with lower than expected prescriptions for angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers (ACE/ARBs), beta-blockers and statins. People with affective disorder had an odds ratio of 0.75 (95% CI 0.55–1.02) but this was not significant. Individuals with a history of other (miscellaneous) mental illness had an odds ratio of 0.95 (95% CI 0.92–0.98) of comparable medication with lower receipt of ACE/ARBs but not highly active antiretroviral therapy (HAART) medication. Results were significant in both adjusted and unadjusted analyses.
Conclusions
Individuals with severe mental illness (including schizophrenia) appear to be prescribed significantly lower quantities of several common medications for medical disorders, largely for cardiovascular indications, although further work is required to clarify to what extent this is because of prescriber intent    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2042438, encodeId=05fc204243823, content=<a href='/topic/show?id=d728e65519c' target=_blank style='color:#2F92EE;'>#精神病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76551, encryptionId=d728e65519c, topicName=精神病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Fri Jul 05 06:42:00 CST 2013, time=2013-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1982728, encodeId=de4a1982e28b0, content=<a href='/topic/show?id=89c4e06902e' target=_blank style='color:#2F92EE;'>#疾病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70690, encryptionId=89c4e06902e, topicName=疾病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Thu Jul 04 00:42:00 CST 2013, time=2013-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921595, encodeId=7fbc19215950e, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Sun Oct 13 01:42:00 CST 2013, time=2013-10-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2042438, encodeId=05fc204243823, content=<a href='/topic/show?id=d728e65519c' target=_blank style='color:#2F92EE;'>#精神病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76551, encryptionId=d728e65519c, topicName=精神病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Fri Jul 05 06:42:00 CST 2013, time=2013-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1982728, encodeId=de4a1982e28b0, content=<a href='/topic/show?id=89c4e06902e' target=_blank style='color:#2F92EE;'>#疾病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70690, encryptionId=89c4e06902e, topicName=疾病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Thu Jul 04 00:42:00 CST 2013, time=2013-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921595, encodeId=7fbc19215950e, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Sun Oct 13 01:42:00 CST 2013, time=2013-10-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2042438, encodeId=05fc204243823, content=<a href='/topic/show?id=d728e65519c' target=_blank style='color:#2F92EE;'>#精神病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76551, encryptionId=d728e65519c, topicName=精神病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Fri Jul 05 06:42:00 CST 2013, time=2013-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1982728, encodeId=de4a1982e28b0, content=<a href='/topic/show?id=89c4e06902e' target=_blank style='color:#2F92EE;'>#疾病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70690, encryptionId=89c4e06902e, topicName=疾病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Thu Jul 04 00:42:00 CST 2013, time=2013-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921595, encodeId=7fbc19215950e, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Sun Oct 13 01:42:00 CST 2013, time=2013-10-13, status=1, ipAttribution=)]